Milk and Milk-produce to Counteract the Loss of Muscle Mass and Function in Exercising Older Adults.
NCT ID: NCT01883674
Last Updated: 2014-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
41 participants
INTERVENTIONAL
2012-05-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Examine the efficiency of protein intake after exercise on muscle mass and physical abilities;
* Examine the impact of exercise and proteins on blood lipids (LDL cholesterol, HDL cholesterol, total cholesterol and triglycerides);
* Examine the impact of exercise and proteins on liver enzymes;
* Examine the impact of exercise and proteins on a hormone that controls hunger;
* Evaluate the program's impact on the ability of the body to produce energy.
All participants are exercising (resistance training) and ingest one of the 3 different sources of proteins, immediately after training:
* Milk proteins (from milk beverage)
* Essential amino acids (added to a soya beverage)
* No protein (rice beverage - control group)
Our hypothesis is that proteins from milk will induce a gain in muscle mass and physical function equivalent to the essential amino acids (EAA). We anticipate that both milk proteins and EAA will be both superior to control group.
This would represent an interesting finding since milk is more accessible, palatable and cheaper than essential amino acids commercial mix.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Milk proteins
This group will do a resistance training + milk proteins (milk beverage)
Resistance training
All group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.
Essential amino acids (add to soya bvg)
This group will do a resistance training + essential amino acids (added to soya beverage)
Resistance training
All group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.
No protein (control)
This group will do a resistance training + ingestion of the control beverage (no protein, rice beverage)
Resistance training
All group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance training
All group will exercise 3x/week. Each session of resistance training will last 60min. and will target main muscular groups.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* francophone or understanding French
* muscle mass index \< 10.75 kg/m2 (Janssen et al, 2004)
* body mass index \<30kg/m²
* weight stable (\< 2 kg) for 6 mo
* no resistance exercise for 3 years
* controlled blood pressure for at least 6 months
Exclusion Criteria
* medical treatment influencing metabolism
* statin treatment
* diagnosis or any sign of kidney disease
65 Years
75 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dairy Farmers of Canada
OTHER
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle J. Dionne, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre de recherche sur le vieillissement
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PLC-021742
Identifier Type: -
Identifier Source: org_study_id